MPL and leukemia: Hypermetylation of miR-203 is not specific for Philadelphia-positive leukemias but is present in Philadelphia negative MPN.   67  MiR-28 targets the 3' UTR region of thrombopoietin receptor (MPL) and suppresses its translation.